Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin M O'Shaughnessy

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Current Hypertension Reports|August 4, 2006
Role of diet in hypertension managementKevin M O'Shaughnessy
Genome Medicine|May 15, 2009
Dissecting complex traits: recent advances in hypertension genomicsKevin M O'Shaughnessy
Pediatric Nephrology (Berlin, Germany)|December 16, 2014
Gordon Syndrome: a continuing storyKevin M O'Shaughnessy
British Journal of Clinical Pharmacology|May 26, 2006
HapMap, pharmacogenomics, and the goal of personalized prescribingKevin M O'Shaughnessy
Genes|October 28, 2023
Genetic Markers Regulating Blood Pressure in Extreme Discordant Sib PairsYasmin, Kevin M O'Shaughnessy
Clinical Science (London, England : 1979)|April 30, 2008
Genetics of arterial structure and function: towards new biomarkers for aortic stiffness?Yasmin, Kevin M O'Shaughnessy
BMJ (Clinical Research Ed.)|April 28, 2016
Authors' reply to Ninan and Millar and Abou-salehKevin M O'Shaughnessy, Lucinda Kennard
Clinical and Experimental Pharmacology & Physiology|May 21, 2013
Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemiaMark Glover, Kevin M O'Shaughnessy
American Journal of Physiology. Endocrinology and Metabolism|October 16, 2008
Both TASK-3 and TREK-1 two-pore loop K channels are expressed in H295R cells and modulate their membrane potential and aldosterone secretionTanja Brenner, Kevin M O'Shaughnessy
BMJ (Clinical Research Ed.)|February 18, 2016
Treating hypertension in patients with medical comorbiditiesLucinda Kennard, Kevin M O'Shaughnessy
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Current Hypertension Reports|August 4, 2006
Role of diet in hypertension managementKevin M O'Shaughnessy
Genome Medicine|May 15, 2009
Dissecting complex traits: recent advances in hypertension genomicsKevin M O'Shaughnessy
Pediatric Nephrology (Berlin, Germany)|December 16, 2014
Gordon Syndrome: a continuing storyKevin M O'Shaughnessy
British Journal of Clinical Pharmacology|May 26, 2006
HapMap, pharmacogenomics, and the goal of personalized prescribingKevin M O'Shaughnessy
Genes|October 28, 2023
Genetic Markers Regulating Blood Pressure in Extreme Discordant Sib PairsYasmin, Kevin M O'Shaughnessy
Clinical Science (London, England : 1979)|April 30, 2008
Genetics of arterial structure and function: towards new biomarkers for aortic stiffness?Yasmin, Kevin M O'Shaughnessy
BMJ (Clinical Research Ed.)|April 28, 2016
Authors' reply to Ninan and Millar and Abou-salehKevin M O'Shaughnessy, Lucinda Kennard
Clinical and Experimental Pharmacology & Physiology|May 21, 2013
Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemiaMark Glover, Kevin M O'Shaughnessy
American Journal of Physiology. Endocrinology and Metabolism|October 16, 2008
Both TASK-3 and TREK-1 two-pore loop K channels are expressed in H295R cells and modulate their membrane potential and aldosterone secretionTanja Brenner, Kevin M O'Shaughnessy
BMJ (Clinical Research Ed.)|February 18, 2016
Treating hypertension in patients with medical comorbiditiesLucinda Kennard, Kevin M O'Shaughnessy
Pageof 6